AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026Net buying: insiders sold $0 and bought $162K on the open market in 90 days (SEC Form 4). Congress: net selling of $185K to $499K in 180 days.
- Company insidersSEC Form 4, last 90 days
- +$162K netNet buying
- CongressSTOCK Act, last 180 days
- -$185K to -$499K netNet selling
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 10 added, 3 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 30- Open
- $132.58
- 52-wk high
- $354.88
- High
- $133.49
- 52-wk low
- $126.40
- Low
- $130.80
- Prev close
- $133.11
- Mkt cap
- $9.21B
- P/E
- 25.0x
- Volume
- 1.37M
- Fwd P/E
- 55.0x
- Beta
- 1.08
- P/S
- 3.0x
- P/B
- 15.0x
- Profit margin
- +12.3%
- Op margin
- +16.2%
- ROE
- +26.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about PODD filings
Are insiders buying or selling Insulet Corporation (PODD) stock?
Net buying: insiders sold $0 and bought $162K of PODD stock on the open market in the 90 days to Oct 1, 2026, according to SEC Form 4 filings. The largest was McEvoy, Ashley (President and CEO), who bought $162K. The latest filing was on Aug 24, 2026.
Which members of Congress have traded PODD recently?
Rep. Gilbert Cisneros (D) bought $1K to $15K on Aug 18, 2026, disclosed 23 days later. Sen. Tina Smith (D) sold $100K to $250K on May 7, 2026, disclosed 3 days later. Sen. Tina Smith (D) sold $100K to $250K on Apr 29, 2026, disclosed 11 days later. In total, 2 members disclosed 3 PODD trades with trade dates in the last 180 days, filed a median 11 days after trading.
How current is this PODD smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net buying.
What funds are doing
Buys/Adds (3)
- TS
Two Sigma
$129.9M
added
- CI
Citadel
$89.1M
added
- MI
Millennium
$69.1M
added
What insiders are doing
Buys (2)
- MA
Mcevoy Ashley
$162K
bought
- ST
Stonesifer Timothy C.
$400K
bought
Sells (1)
- BL
Borio Luciana
$60K
sold
What Congress is doing
Buys (1)
Sells (2)
How top traders are positioned
No tracked top-trader positions in PODD right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 15.3% above what analysts expected.
Earnings per share
$1.44 expected
Reports Nov 5, 2026, in 35 days
Estimates as of Sep 29, 2026
EPS expected
$1.50 to $1.66
Revenue expected
22 analysts
Last 30 days
Analysts cutting estimates
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $706.3M | $783.8M | $761.7M | $801.7M |
| Cost of what it sold | $196.2M | $215.2M | $232.6M | $239.1M |
| Gross profit | $510.1M | $568.6M | $529.1M | $562.6M |
| What it spent | ||||
| Research and development | $77.2M | $90.9M | $89.7M | $88.1M |
| Sales and admin | $315.2M | $331.4M | $317.2M | $344.8M |
| Total operating expenses | $392.4M | $422.3M | $406.9M | $432.9M |
| What was left | ||||
| Operating profit | $117.7M | $146.3M | $122.1M | $129.7M |
| Interest on debt | $15.6M | $19.6M | $14.7M | $13.5M |
| Profit before tax | $122.8M | $140.2M | $113.0M | $118.7M |
| Tax | $35.2M | $38.5M | $21.9M | $23.7M |
| Net profit | $87.6M | $101.6M | $91.1M | $95.0M |
| EBITDA | $160.4M | $190.4M | $153.9M | $132.2M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is mixed
Insulet Targets Type 2 Retention as Omnipod 6 and Global Growth Gain Momentum
BullishSep 25Insulet stock heads into the open after a 0.1 percent rise
NeutralSep 25How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks?
BearishSep 24STAAR Surgical Company (STAA) Stock Price, News, Quote & History
NeutralSep 23Insulet stock trades 60.9 percent below its 52-week high
NeutralSep 23Wells Fargo initiates Beta Bionics stock with overweight rating
NeutralSep 23Insulet stock heads into the open after a 0.8 percent drop
NeutralSep 23Insulet Amends Credit Facilities, Expands Revolving Commitments
Leans bullishSep 22
Macro
22 macro signals shaping PODD right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results